CAH vs IRWD · P/E 35, rev $254.25B vs P/E 5.7, rev $219.5M
Cardinal Health Inc (CAH) versus Ironwood Pharmaceuticals Inc (IRWD) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Not investment advice. Open the CAH and IRWD stock pages for the full models.
Not investment advice.